• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TG Therapeutics, Inc. - Common Stock (NQ:TGTX)

54.29 +0.67 (+1.25%)
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,661,808
Open 54.17
Bid (Size) 53.70 (1,000)
Ask (Size) 54.59 (1,000)
Prev. Close 53.62
Today's Range 53.15 - 54.98
52wk Range 26.76 - 59.30
Shares Outstanding 154,420,772
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
TG Therapeutics (NASDAQ:TGTX) Combines Strong Growth With a Tight Technical Breakout Setup ↗
September 21, 2026
Via Chartmill
News headline image
TG Therapeutics Eyes $1B Run Rate as BRIUMVI Gains MS Market Share ↗
September 18, 2026
TG Therapeutics (NASDAQ:TGTX) Chairman, President and Chief Executive Officer Mike Weiss said the company’s multiple sclerosis therapy, BRIUMVI, has captured more than one-third of the intravenous... 
Via MarketBeat

Performance

52-Week Range 8.4% below 52-week high
54.29
26.7652W Low 59.3052W High
1 Week 5.8% below 1-week high
53.151W Low 57.661W High

TG Therapeutics, Inc. - Common Stock (TGTX) traded between $26.76 and $59.30 over the past 52 weeks and last traded at $54.29, 8.4% below its 52-week high. Over the past week it ranged between $53.15 and $57.66.

Past 12 Months
-3.4%
-4.6%
-2.1%
+61.1%
+85.4%
+48.1%
1W -$1.90
1M -$2.61
3M -$1.18
6M +$20.60
YTD +$25.01
1Y +$17.63

TGTX was +48.1% over the past year, +61.1% over six months, +85.4% year to date, -3.4% in the last week.

12 Months vs Market
TGTX
+48.1%
DIA
+9.9%
SPY
+15.0%
QQQ
+23.7%
IWM
+15.4%

Over the past 12 months TGTX returned +48.1% versus DIA (Dow) +9.9%, SPY (S&P 500) +15.0%, QQQ (Nasdaq 100) +23.7% and IWM (Russell 2000) +15.4%.

Volume & Liquidity 0.82× 3-mo avg
Today 1,661,808 3-mo avg 2.0M
1W
1.7M
1M
1.8M
3M
2.0M
6M
2.2M
YTD
2.2M
1Y
2.1M

TGTX most recently traded 1,661,808 shares against a 3-month average daily volume of 2.0M.

More News

Read More
MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Lucid-MS Toward Phase 2 Trial Following FDA Clearance
September 10, 2026
Via Investor Brand Network
Historic First in MS Treatment Could Reshape a Multibillion-Dollar Therapeutics Market
September 10, 2026
Via Investor Brand Network
TG Therapeutics (NASDAQ:TGTX): A Fitting Candidate for Affordable Growth ↗
August 31, 2026
Via Chartmill
TG Therapeutics (NASDAQ:TGTX) Combines Strong Growth with a Breakout Setup ↗
August 19, 2026
Via Chartmill
TG Therapeutics (NASDAQ:TGTX) Falls as Q2 Revenue Beats but EPS Misses, Guidance Raised Below Estimates ↗
August 03, 2026
Via Chartmill
TG Therapeutics (NASDAQ:TGTX) Meets Minervini's Trend Template with Accelerating Growth ↗
July 29, 2026
Via Chartmill
MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Advances Lucid-MS Toward Phase 2 Trial Following FDA Clearance
September 10, 2026
Via Investor Brand Network
News headline image
Historic First in MS Treatment Could Reshape a Multibillion-Dollar Therapeutics Market
September 10, 2026
From BioMedWire
Via GlobeNewswire
TG THERAPEUTICS INC (NASDAQ:TGTX): High-Growth Momentum Meets Minervini Trend Template Technical Strength ↗
July 02, 2026
Via Chartmill
TG THERAPEUTICS INC (NASDAQ:TGTX) Screens as Affordable Growth Play with Strong Revenue Surge and Discounted Valuation ↗
May 09, 2026
Via Chartmill
News headline image
TG Therapeutics Conference: 908 Devices Bets on Handheld Drug, Chemical Detection ↗
August 17, 2026
Via MarketBeat
News headline image
TG Therapeutics (TGTX) Q2 2026 Earnings Call Transcript ↗
August 10, 2026
Via The Motley Fool
Topics Earnings
News headline image
TG Therapeutics Q2 Earnings Call Highlights ↗
August 03, 2026
Via MarketBeat
Topics Earnings
News headline image
2 Fast-Growing Pharmaceutical Stocks to Buy Now ↗
July 08, 2026
Via The Motley Fool
The Quest to Repair What Multiple Sclerosis Takes Away
June 24, 2026
Via Investor Brand Network
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Lucid-MS Toward Phase 2 Trials for Multiple Sclerosis
June 24, 2026
Via Investor Brand Network
News headline image
The Quest to Repair What Multiple Sclerosis Takes Away
June 24, 2026
From BioMedWire
Via GlobeNewswire
News headline image
TG Therapeutics Stock Surges After Drug Trial Update ↗
June 03, 2026
Via Benzinga
News headline image
Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More ↗
May 30, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Structure Therapeutics Stock Is Up 47%, but One Fund Just Fully Exited a $2.6 Million Position ↗
May 10, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why One Fund’s $4 Million Alumis Buy Looks Like a Bet on a Breakthrough Autoimmune Drug ↗
May 10, 2026
Via The Motley Fool
News headline image
TG Therapeutics (TGTX) Q1 2026 Earnings Transcript ↗
May 06, 2026
Via The Motley Fool
News headline image
TGTX Q1 2025 Earnings Call Transcript ↗
May 06, 2026
Via The Motley Fool
Topics Earnings

Frequently Asked Questions

Is TG Therapeutics, Inc. - Common Stock publicly traded?
Yes, TG Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does TG Therapeutics, Inc. - Common Stock trade on?
TG Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for TG Therapeutics, Inc. - Common Stock?
The ticker symbol for TG Therapeutics, Inc. - Common Stock is TGTX on the Nasdaq Stock Market
What is the current price of TG Therapeutics, Inc. - Common Stock?
The current price of TG Therapeutics, Inc. - Common Stock is 54.29
When was TG Therapeutics, Inc. - Common Stock last traded?
The last trade of TG Therapeutics, Inc. - Common Stock was at 10/02/26 04:00 PM ET
What is the market capitalization of TG Therapeutics, Inc. - Common Stock?
The market capitalization of TG Therapeutics, Inc. - Common Stock is 8.38B
How many shares of TG Therapeutics, Inc. - Common Stock are outstanding?
TG Therapeutics, Inc. - Common Stock has 8B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap